Home Hot keywords

Search Modes

Search Results

PRASINEZUMAB
Jul 20, 2021Prasinezumab is a humanized IgG1 monoclonal antibody directed against aggregated α-synuclein. Genetic and pathological evidence suggest that ...
People also ask
Oct 1, 2021Prasinezumab (previously known as RO7046015/PRX002) is an investigational, humanized monoclonal immunoglobulin G1 antibody directed against ...
This multicenter, randomized, double-blind, placebo-controlled, Phase 2 study will evaluate the efficacy of intravenous prasinezumab (RO7046015/PRX002) ...
Sep 18, 2021Treatment with prasinezumab (Roche), an investigational humanized monoclonal antibody previously known as PRX002, resulted in slight delay ...
Oct 1, 2021The phase 2 PASADENA study (NCT03100149) was a randomized, placebo-controlled trial that evaluated the efficacy and safety of prasinezumab ...
Mar 16, 2021Prasinezumab is an α-synuclein mAb administered intravenously as an infusion. Normally, α-synuclein is found in an unstructured soluble form ...
Feb 22, 2021It is a glucosylceramide synthase inhibitor that acts by targeting the GBA mutation found in up to 10% of PD ...
Sep 13, 2021Prasinezumab is an experimental drug, which means that the FDA has ... Prasinezumab is a type of medication called a 'monoclonal antibody'.
by G Pagano2021Cited by 3Objective: The study objective was to evaluate the efficacy and safety of prasinezumab, a humanized monoclonal …

google search trends